<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01088269</url>
  </required_header>
  <id_info>
    <org_study_id>BPM IN AF</org_study_id>
    <nct_id>NCT01088269</nct_id>
  </id_info>
  <brief_title>Blood Pressure Assessment in Atrial Fibrillation</brief_title>
  <official_title>Evaluation of the Oscillometric Blood Pressure Measurement in Atrial Fibrillation and Relation of Blood Pressure With Serum Biomarkers and Echocardiographic Indexes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Athens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Athens</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a cross-sectional study including patients with permanent atrial fibrillation.
      Assessment will include:

        -  clinic blood pressure measurements (mercury sphygmomanometer and automated oscillometric
           device)

        -  24-hour ambulatory blood pressure monitoring

        -  determination of various serum markers and cardiac ultrasound.

        -  evaluation of a 24h ambulatory blood pressure monitoring device (Microlife WatchBPO3) in
           terms of its diagnostic value for the detection of atrial fibrillation compared with the
           reference 24h Holter ECG
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2010</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Blood Pressure Measurement in Atrial Fibrillation,Serum Markers and echocardiographic indexes in atrial fibrillation (AF)</measure>
    <time_frame>Baseline</time_frame>
    <description>Evaluation of the oscillometric technique of an electronic device in blood pressure measurement.
Evaluation of the relationship of blood pressure levels with serum markers and ultrasonographic cardiac indexes.
Evaluation of a 24h ambulatory blood pressure monitoring device (Microlife WatchBPO3) in terms of its diagnostic value for the detection of atrial fibrillation compared with the reference 24h Holter ECG</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>AF</arm_group_label>
    <description>Hypertensive patients in AF</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-AF</arm_group_label>
    <description>Hypertensive Patients</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        SUBJECTS REFERRED TO HYPERTENSION CENTER
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Hypertensives adults in atrial fibrillation

        Exclusion Criteria:

          -  Renal disease (Cr &gt; 2 mg/l).

          -  Patients with pacemaker rhythm during the study.

          -  Each patient with acute disease (inflammation, surgery), malignancy, collagen
             diseases, pulmonary fibrosis, renal failure, liver failure, chronic inflammatory
             diseases.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>George S Stergiou, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hypertension Center,Third Department of Medicine,University of Athens,Greece</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>George S Stergiou, MD</last_name>
    <phone>+302107763117</phone>
    <email>gstergi@med.uoa.gr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hypertension Center, Third Internal Medicine Dpt, University of Athens</name>
      <address>
        <city>Athens</city>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>George S. Stergiou</last_name>
      <phone>00302107763117</phone>
      <email>gstergi@med.uoa.gr</email>
    </contact>
    <contact_backup>
      <last_name>George S. Stergiou, Professor</last_name>
      <phone>00302017763117</phone>
      <email>gstergi@med.uoa.gr</email>
    </contact_backup>
    <investigator>
      <last_name>Antonios Th. Destounis, Phd candidate</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 16, 2010</study_first_submitted>
  <study_first_submitted_qc>March 16, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 17, 2010</study_first_posted>
  <last_update_submitted>September 13, 2017</last_update_submitted>
  <last_update_submitted_qc>September 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Athens</investigator_affiliation>
    <investigator_full_name>George S. Stergiou</investigator_full_name>
    <investigator_title>Associate Professor of Medicine and Hypertension</investigator_title>
  </responsible_party>
  <keyword>Blood Pressure Measurement</keyword>
  <keyword>Atrial Fibrillation</keyword>
  <keyword>Blood pressure measurement in atrial fibrillation</keyword>
  <keyword>Atrial Fibrillation diagnosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

